From the Shareholder Update 28th April:-
“Starpharma commenced its double-blinded, placebo- controlled safety study to support marketing of VIRALEZETM in January 2021. The study involved 40 healthy volunteers, using the product 4 times a day for 14 consecutive days. All participants have now completed the study. Whilst the data is not yet unblinded, both VIRALEZETM and the placebo nasal spray were extremely well tolerated by all participants.”
Still waiting waiting waiting...
Results from Perth nasal spray study? Did we get them?, page-6
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
